Your child comes home from school with a high fever, runny nose, and red, watery eyes — and three days later, a distinctive red rash erupts behind the ears and spreads rapidly down to the face, neck, and body. This progression is classic measles, and it is not as rare as you might think. India reported 7,201 measles cases between September 2024 and March 2025 alone — ranking second globally after Yemen. Maharashtra has repeatedly been the epicentre, but outbreaks have also flared in Gujarat, Kerala, Uttar Pradesh, and Madhya Pradesh, particularly in urban slums where vaccination coverage lags. The global resurgence — including a major US outbreak in 2025 — is a sharp reminder that measles does not stay away if vaccination rates slip.
The good news: measles is entirely preventable with a vaccine that India provides free of cost through the government's Universal Immunisation Programme (UIP). Understanding the disease, the vaccine schedule, and what to do when measles is suspected can protect your child and your community.
What Is Measles?
Measles (known as Khasra in Hindi, Golu in Tamil, Goambal in Marathi) is a highly contagious viral respiratory infection caused by the measles virus — a paramyxovirus. It is one of the most infectious diseases known to medicine: a single person with measles can infect 12–18 susceptible contacts (higher than even COVID-19 or influenza). The virus travels through airborne droplets and can remain infectious in the air for up to two hours after an infected person has left a room.
Rubella (German measles) is a separate, milder viral infection also caused by a paramyxovirus. India now vaccinates against both using the combined MR vaccine (Measles-Rubella). Rubella is particularly dangerous in pregnancy — the virus can cross the placenta and cause Congenital Rubella Syndrome (CRS), leading to deafness, cataracts, heart defects, and intellectual disability in newborns.
Why Is India Still Seeing Measles Outbreaks?
Despite decades of vaccination, India still experiences periodic outbreaks because:
- Pockets of low vaccination coverage persist in urban slums, tribal districts, and migrant communities where families move frequently
- Vaccine hesitancy has slowed catch-up immunisation in some communities
- Missed second doses — even children who received the first dose may not have returned for the critical second dose, leaving partial protection
- COVID-19 disruption (2020-21) interrupted routine immunisation in millions of children, creating a "susceptibility gap" that fuelled the 2022-23 Maharashtra outbreak
- Waning immunity without booster in older children who received only one dose
India's government responded with the National Zero Measles-Rubella Elimination Campaign — vaccinating 30 million children in 7 months — and achieved a remarkable 73% decline in measles cases in 2024. However, elimination requires sustained ≥95% two-dose coverage in every district.
Symptoms of Measles: What to Watch For
Measles unfolds in four distinct stages. Knowing each stage helps you identify the disease early and prevent spreading it to unvaccinated contacts.
Stage 1: Incubation Period (10–14 Days)
The virus silently replicates in the lymph nodes. No symptoms yet, but the person is already infected and will become contagious as early as Day 9.
Stage 2: Prodromal Phase (3–5 Days — Most Contagious)
The classic "3 Cs" begin:
- Coryza — severe runny nose
- Cough — hacking, persistent
- Conjunctivitis — redness, watering, and sensitivity to light (photophobia)
Combined with high fever (103°F–105°F / 39.5°C–40.5°C), this phase is easily mistaken for a common cold or flu. However, Koplik's spots — tiny white spots on a red base on the inner cheek mucosa (like grains of salt on a red background) — are pathognomonic for measles. They appear 1–2 days before the rash and last 2–3 days. Seeing Koplik's spots means a measles diagnosis is certain.
Stage 3: Rash Phase (3–5 Days)
The characteristic maculopapular rash appears:
- Starts behind the ears and at the hairline
- Spreads downward to the face, neck, trunk, arms, and finally the legs over 3 days
- Confluent on the face; more discrete on the extremities
- The child looks most unwell during this stage — fever peaks, Koplik's spots disappear, and the child is miserable
- The rash is not itchy (unlike chickenpox, which is intensely itchy)
Stage 4: Recovery Phase (3–5 Days)
The rash fades in the same order it appeared (head to toe). Fever subsides. The child recovers, but fatigue and cough may persist for weeks. Post-measles immune suppression — a period of 2–3 years during which the measles virus destroys immune memory — increases susceptibility to other infections.
Key Differences: Measles vs Chickenpox vs Dengue
| Feature | Measles (Khasra) | Chickenpox (Chickenpox) | Dengue |
|---|---|---|---|
| Rash type | Maculopapular (flat/raised), not itchy | Vesicular (fluid-filled blisters), very itchy | Maculopapular; may be petechial |
| Rash progression | Head to toe (top-down) | Begins on trunk, spreads outward | Can be anywhere |
| Fever timing | Before and during rash | Appears with or just before rash | Before or with rash |
| Eye involvement | Redness, watering (conjunctivitis) | Not typical | Not typical |
| Koplik's spots | Yes (inner cheek) | No | No |
| Cough/cold | Yes — severe "3 Cs" | Mild | Not typical |
Complications: Why Measles Is Dangerous
In India, measles kills primarily through its complications, not the rash itself. Children under 5, malnourished children, and those with vitamin A deficiency are at highest risk.
Common Complications
- Pneumonia — the leading cause of measles death (30–60% of measles deaths); secondary bacterial pneumonia occurs in immunosuppressed children
- Otitis media (ear infection) — affects 5–9% of measles cases; can cause permanent hearing loss
- Diarrhoea and dehydration — common in malnourished children; worsens malnutrition
- Croup (laryngotracheobronchitis) — airway inflammation causing barking cough and breathing difficulty
- Febrile seizures — relatively common (6–7%) due to high fever
Severe (But Less Common) Complications
- Encephalitis — brain inflammation occurring 1 in 1,000 measles cases; can cause permanent neurological damage or death
- Subacute Sclerosing Panencephalitis (SSPE) — a fatal, progressive neurological disorder developing 7–10 years after measles infection; affects 1 in 8,700 cases (higher risk if infected under age 2); India has among the highest SSPE rates globally
- Blindness — from corneal ulceration, especially in vitamin A-deficient children; a major complication in tribal and rural India
- Measles in pregnancy — increases miscarriage, preterm birth, and maternal mortality risk
Vitamin A and Measles in India
The WHO and IAP recommend Vitamin A supplementation for all children with measles, as it reduces measles mortality by up to 50%:
- Children 6–11 months: 100,000 IU single dose
- Children ≥12 months: 200,000 IU single dose; repeat next day; repeat 4 weeks later if there are eye or nutritional deficiency signs
Vitamin A supplementation is available at government hospitals and is part of the free NRHM child health package.
MR Vaccine: Your Child's Protection
The Measles-Rubella (MR) vaccine is the most effective prevention — the government provides it free of cost under UIP, and it is highly safe with decades of use globally. India's homegrown MR vaccine is manufactured by the Serum Institute of India (SII) — one of the world's largest vaccine producers.
Free UIP Schedule (Universal Immunisation Programme)
| Dose | Age | Vaccine | Where Available |
|---|---|---|---|
| First dose (MR1) | 9–12 months | MR vaccine | Government health centres, Anganwadi (free) |
| Second dose (MR2) | 16–24 months | MR vaccine | Government health centres (free) |
IAP (Indian Academy of Pediatrics) Recommended Schedule
The IAP recommends an additional MMR (Measles-Mumps-Rubella) dose for children whose parents want broader protection including mumps:
| Dose | Age | Vaccine | Cost in Private Clinics |
|---|---|---|---|
| MMR 1 | 12–15 months | MMR (Tresivac, Priorix, M-M-R II) | ₹500–1,500 |
| MMR 2 | 4–6 years | MMR | ₹500–1,500 |
Important: Two doses offer 97% protection against measles. One dose provides 93% protection — the second dose closes this gap and boosts long-term immunity.
What if My Child Missed a Dose?
Catch-up vaccination is always possible and recommended. If your child missed either the first or second MR/MMR dose at the scheduled age, consult your paediatrician immediately:
- The second dose can be given as late as the same visit if the child is ≥4 weeks after the first dose
- Older children who were never vaccinated should receive 2 doses (4 weeks apart)
- Children who received only measles vaccine (not MR) should get an MR/MMR dose for rubella protection
Vaccine Safety: Addressing Concerns
The MR and MMR vaccines are among the most rigorously studied in medical history. Common mild side effects (normal, expected) include:
- Sore arm at injection site (1–2 days)
- Low-grade fever 7–12 days after vaccination (immune response to vaccine, not illness)
- Mild rash for 1–2 days (7–12 days post-vaccination)
The widely circulated claim that MMR vaccine causes autism has been comprehensively disproven across dozens of studies involving millions of children. The original 1998 study making this claim was found to be fraudulent and retracted by the journal. The IAP, WHO, CDC, and every major medical body have repeatedly confirmed the MMR vaccine's safety.
Diagnosing Measles: When to Test
Measles is primarily diagnosed clinically — a doctor can typically diagnose it from the characteristic symptoms. However, laboratory confirmation is important for:
- Suspected cases outside of known outbreaks
- Unusual presentations (immunocompromised patients)
- Public health surveillance and outbreak verification
Tests for Measles
| Test | What It Detects | Timing | Cost (INR) |
|---|---|---|---|
| IgM serology (blood) | Measles IgM antibodies | Within 3 days of rash onset; peaks at 7–10 days | ₹600–1,500 |
| RT-PCR (throat swab/urine) | Measles virus RNA | Most sensitive in first 3 days of rash | ₹1,500–3,000; available at government reference labs |
| IgG avidity test | Past infection vs. recent infection | Used in epidemiology | Not routine |
For government outbreak investigation, samples can be sent to National Polio Surveillance Programme (NPSP) measles laboratories — there is no charge to patients in outbreak settings.
Treatment: What to Do if Your Child Has Measles
There is no antiviral treatment specific to measles. Management is supportive and focused on preventing complications.
At-Home Care
- Paracetamol (Calpol, Dolo) — for fever control; do NOT use aspirin in children (risk of Reye's syndrome)
- Adequate fluid intake — ORS (ORS-WHO formula, Electral sachets) for children with diarrhoea; encourage frequent small sips
- Rest and isolation — the child is infectious from 4 days before to 4 days after rash appearance; keep away from unvaccinated contacts and infants
- Vitamin A — ask your paediatrician for the appropriate dose (see above)
- Eye care — clean discharge with clean, moist cloth; keep the room dimly lit if photophobia is severe
- Nutritious diet — khichdi, dal, curd, soft cooked vegetables; protein helps recovery
When to Seek Emergency Care Immediately
Take your child to a hospital without delay if they develop:
- Difficulty breathing / rapid breathing / chest indrawing
- High fever not responding to paracetamol (>105°F / 40.5°C)
- Seizures (convulsions)
- Extreme lethargy or inability to wake up
- Eye pain or cloudy cornea (risk of blindness)
- Signs of dehydration (sunken eyes, no tears, very dark urine)
Hospital Treatment
Hospitalised cases receive:
- Oxygen therapy if oxygen saturation is low
- IV fluids for dehydration
- Antibiotics for secondary bacterial pneumonia
- High-dose Vitamin A (as above)
- Intensive care for encephalitis
Treatment at government hospitals under PM-JAY / Ayushman Bharat is available free of cost. Read more about Ayushman Bharat PM-JAY coverage.
Measles During Pregnancy: Special Risks
Measles infection in pregnancy is dangerous for both mother and baby:
- Higher risk of preterm labour and miscarriage
- Increased severity of pneumonia in the mother
- Newborn can be born with measles (neonatal measles) if the mother was infectious near delivery
- Rubella (in the combined MR vaccine) causes Congenital Rubella Syndrome — which is why the vaccine is given before pregnancy
The MR vaccine should NOT be given during pregnancy. Pregnant women who are not immune to measles should be vaccinated after delivery. If a pregnant woman is exposed to measles, she should receive Human Normal Immunoglobulin (HNIG) injections within 6 days — available at government medical colleges.
Tracking Your Child's Vaccination Record
One of the most important steps every Indian parent can take is to maintain an accurate vaccination record for every child in the family. Vaccination records are needed for school admissions, travel, and if your child ever develops a fever illness — knowing which vaccines they received (and when) helps doctors rule out or confirm diseases quickly.
Use MedicalVault's family sharing feature to store each child's vaccination records digitally, set reminders for upcoming doses, and share records instantly with schools or paediatricians. You can also store your antenatal vaccination history alongside your child's records using MedicalVault's report upload. Read our full child vaccination schedule guide for a trimester-by-trimester and age-by-age breakdown.
Key Takeaways
- Measles (khasra) is a highly contagious viral disease that remains active in India, with 7,201 cases reported in September 2024–March 2025, concentrated in Maharashtra, Gujarat, and urban slums
- The "3 Cs" — coryza, cough, conjunctivitis — plus high fever and the distinctive head-to-toe rash are the hallmarks; Koplik's spots inside the cheek confirm the diagnosis
- Dangerous complications include pneumonia, encephalitis, blindness, and SSPE (a fatal brain disease); malnourished and vitamin A-deficient children are at highest risk
- Two doses of MR vaccine are given free under the UIP at 9–12 months and 16–24 months; two doses provide 97% protection
- Vitamin A supplementation (200,000 IU) should be given to all measles-positive children to halve mortality risk
- There is no antiviral treatment — prevention through vaccination is the only solution
- Keep all family vaccination records organised and accessible with MedicalVault's digital health records so you're always ready when it matters